Update Your ProfileAcademic Title:
Faculty Member
Primary Appointment:
Psychiatry
Education and Training
2010, BS, Psychology, Davidson College
2010, BS, Biology, Davidson College
2019, PhD, Human Behavioral Pharmacology/Experimental Psychology, University of Kentucky
2021, Postdoctoral Training, Johns Hopkins University School of Medicine
Biosketch
My program of work focuses on developing novel interventions for substance use and substance use disorder using translationally relevant designs. This research includes applying behavioral economic methods to evaluate choice and decision-making mechanisms that may underlie substance use and identify targets for their reduction. I am particularly focused on how the combination of preclinical, human behavioral pharmacology, and clinical trial methods can be applied in an interventions development pipeline using traditional and novel behavioral assays.
Research/Clinical Keywords
addiction, behavioral economics, decision making, reward, self-administration, translational
Highlighted Publications
Strickland JC, Havens JR, Stoops WW. A nationally representative analysis of "twin epidemics": Rising rates of methamphetamine use among persons who use opioids. Drug Alcohol Depend. 2019;204:107592.
Strickland JC, Campbell EM, Lile JA, Stoops WW. Utilizing the commodity purchase task to evaluate behavioral economic demand for illicit substances: a review and meta-analysis. Addiction. 2020;115(3):393-406.
Strickland JC, Lacy RT. Behavioral economic demand as a unifying language for addiction science: Promoting collaboration and integration of animal and human models. Exp Clin Psychopharmacol. 2020;28(4):404-16.
Strickland JC, Acuff SF. Role of social context in addiction etiology and recovery. Pharmacol Biochem Behav. 2023;229:173603.
Strickland JC, Tilton HE, Patton NM, Vandrey R, Zamarripa CA, Spindle TR, Lee D, Bergeria CL, Wolinsky D, Klawitter J, Sempio C, Campos-Palomino J, Christians U, Feldner MT, Irons JG, Bonn-Miller MO. Effect of caffeine and cannabidiol (CBD) co-administration on Δ9-tetrahydrocannabinol (Δ9-THC) subjective effects, performance impairment, and pharmacokinetics. Neuropsychopharmacology. 2025;1827-1835.
Awards and Affiliations
2020 Division 28 Outstanding Dissertation Award, Division 28 American Psychological Association
2022 B.F. Skinner Foundation New Researcher Award (Basic Science), Division 25 American Psychological Association
2023 Joseph Cochin Young Investigator Award, College on Problems of Drug Dependence
Grants and Contracts
NIH/NIDA R01 DA055634 (Role: PI)- “Influence of Orexin Antagonism on Opioid and Methamphetamine Demand”
NIH/NIDA R01 DA057925 (Role: MPI)- “Evaluation of the Electronic Cigarette Withdrawal Syndrome: Mechanistic Targets for Intervention”
NIH/NIDA R01 DA058624 (Role: MPI)- “Effect of Cannabinoids on Tobacco Product Demand and Pharmacodynamics”
NIH/NIDA U01 CA294539 (Role: Co-I/Project PI)- “From Perceptions to Behaviors: A Comprehensive Approach to Examine the Impact of Public Health Communication Messaging about the Continuum of Risk for Tobacco Products”